ORIGINAL RESEARCHThe Functional and Structural Consequences of Cavernous Nerve Injury are Ameliorated by Sildenafil Citrate
Introduction
Approximately 50,000 radical prostatectomies (RP) are performed each year in the United States for the treatment of prostate cancer. This operation is associated with at least transient erectile dysfunction (ED), with ED rates ranging from 20% to 90% depending upon the study reviewed 1, 2, 3, 4. It is postulated that the development of post-RP ED is due predominantly to a combination of temporary erectile (cavernous) nerve injury and damage to the erectile tissue secondary to neuropraxia and potentially absence of cavernosal oxygenation [5].
A single human, randomized, placebo-controlled study has been conducted examining the role of nightly sildenafil for a 36-week time period following RP [6]. This study demonstrated the ability of this regimen to increase the rate of preservation of preoperative erectile function at approximately 1 year postoperatively in the sildenafil arm compared with the placebo arm [6]. In another noncontrolled study, Schwartz et al. demonstrated that regular use of sildenafil post-RP preserved cavernosal smooth muscle content [7].
The presumed mechanism of this apparent protective effect of sildenafil was originally believed to be cavernosal oxygenation related to penile erection; however, more recently, some have postulated that sildenafil may have an endothelial or neuroprotective effect [8]. The rat cavernous nerve (CN) injury model is believed to simulate the neural injury that occurs during RP and is designed as a model to study the mechanisms of ED post-RP as well as to explore ED-minimizing strategies [9]. This study was undertaken to generate animal data in support of human studies and to explore the mechanisms by which sildenafil may preserve erectile function in this animal model.
Section snippets
Animal Groupings and Sildenafil Administration
Sprague-Dawley rats, initially weighing 250–300 g, were randomly divided into four groups: (i) sham (no CN crush, no sildenafil); (ii) control (C; bilateral CN crush, no sildenafil); and two treatment groups (bilateral CN crush, sildenafil sc): (iii) sildenafil 10 mg/kg (S10); and (iv) sildenafil 20 mg/kg (S20) subcutaneously daily commencing day of CN crush until 24 hours prior to sacrifice. Within each of the four groups, three time subgroups were analyzed, 3 days, 10 days, and 28 days after CN
Erectile Hemodynamics (Figure 1)
The mean ICP/MAP ratios in the sham group was 70 ± 6% and remained significantly higher compared with all other groups (P < 0.01). However, daily subcutaneous sildenafil commencing the day of CN crush injury, administered at 10 mg/kg (S10) and 20 mg/kg (S20) showed an improvement in the mean ICP/MAP ratio compared with control at all three time points. The control group (C) demonstrated improvement in erectile function over time with the ICP/MAP ratio rising from 18 ± 10% at 3 days to 31 ± 13% at 10
Discussion
The rat model of CN injury was first described by Quinlan in 1989 [10] and has been used extensively to investigate techniques and interventions to prevent ED following RP. We documented in prior experiments the use of this animal model in the assessment of functional and structural changes of erectile tissue after CN injury conducted using various techniques [9]. Our findings in this current series of experiments showed a highly significant reduction in ICP/MAP ratios in animals after CN
Conclusion
We have demonstrated, in the CN crush injury model, that sildenafil citrate preserves erectile function and acts by preserving smooth muscle content, endothelial integrity and reducing apoptosis. At this time, based on TEM data, while there are clear differences in CN architecture between treated and untreated animals, it is unclear if these changes represent a genuine neuroregenerative effect. The pharmacological effect on erectile function recovery is dose- and time-dependent. Furthermore, it
Category 1
- (a)
Conception and Design
John P. Mulhall
- (b)
Acquisition of Data
John P. Mulhall; Alexander Müller; John F. Donohue; Michael Mullerad; Raanan Tal; Keith Kobylarz; Darius A. Paduch; Leona Cohen-Gould
- (c)
Analysis and Interpretation of Data
John P. Mulhall; Alexander Müller; Michael Mullerad; Leona Cohen-Gould
Category 2
- (a)
Drafting the Article
Alexander Müller; Michael Mullerad; John F. Donohue; John P. Mulhall
- (b)
Revising It for Intellectual Content
John P. Mulhall; Michael Mullerad; Alexander Müller
Category 3
- (a)
Final Approval of the Completed
Acknowledgements
This study was funded in part by the Dow Wallace Fund and a research grant from Pfizer Inc.
References (24)
- et al.
Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies
J Urol
(1999) - et al.
Erectile dysfunction after radical prostatectomy: Hemodynamic profiles and their correlation with the recovery of erectile function
J Urol
(2002) - et al.
Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy
J Urol
(2004) - et al.
Penile rehabilitation should become the norm for radical prostatectomy patients
J Sex Med
(2007) - et al.
Functional sequelae of cavernous nerve injury in the rat: Is there model dependency
J Sex Med
(2006) - et al.
The rat as a model for the study of penile erection
J Urol
(1989) - et al.
Apoptosis in the rat penis after penile denervation
J Urol
(1997) - et al.
Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction
J Urol
(2003) - et al.
In vivo analysis of chronic phosphodiesterase-5 inhibitor with sildenafil in penile erectile tissues: No tachyphylaxix effect
J Urol
(2005) - et al.
Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: Lack of tachyphylaxis
Eur Urol
(2005)
Cited by (118)
Pericyte-Derived Extracellular Vesicle–Mimetic Nanovesicles Restore Erectile Function by Enhancing Neurovascular Regeneration in a Mouse Model of Cavernous Nerve Injury
2020, Journal of Sexual MedicineCitation Excerpt :The activation of Akt signaling is known to induce proliferation and migration of various cell types.43 Several previous studies have demonstrated that important angiogenesis factors are decreased after CNI.19,44–46 In addition, it was reported that Schwann cell-derived NVs may induce the expression of neurotrophic factors (BDNF, NT-3, and NGF), which enhance neurite sprouting in vitro.47
European Society for Sexual Medicine Consensus Statement on the Use of the Cavernous Nerve Injury Rodent Model to Study Postradical Prostatectomy Erectile Dysfunction
2020, Sexual MedicineCitation Excerpt :In rodent studies, the exact time frame in which maximal nerve regeneration and EF recovery occurs is not uniformly agreed upon. Commonly, EF is evaluated 4 weeks after nerve injury in rats because it is generally believed to represent the 2-year time in humans.99 Indeed, in humans, EF continues to improve up to 24 months after RP.100
Bilateral Cavernous Nerve Crush Injury in the Rat Model: A Comparative Review of Pharmacologic Interventions
2018, Sexual Medicine Reviews